Nurix Therapeutics Inc
NRIX
NASDAQ
Biotechnology
$27.05
USD
-0.14 (-0.51%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $2.79B
Volume 738.2K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
IRON | Disc Medicine Inc | $3.07B | - | - | - | |
GRAL | Grail Inc | $3.05B | - | +23.1% | - | |
IMNM | Immunome Inc | $3.00B | - | -63.3% | - | |
IOVA | Iovance Biotherapeutics Inc | $2.98B | - | +34.5% | - | |
NRIX | Nurix Therapeutics Inc | $2.79B | - | -58.4% | - | |
BEAM | Beam Therapeutics Inc | $2.73B | - | +158.9% | - | |
RARE | Ultragenyx Pharmaceutical Inc | $2.60B | - | +17.5% | - | |
KOD | Kodiak Sciences Inc | $2.53B | - | - | - | |
SLS | Sellas Life Sciences Group Inc | $2.46B | - | - | - | |
COAG | Hemab Therapeutics Holdings Inc | $2.33B | - | - | - |
Top Peer by Growth
Beam Therapeutics Inc
+158.9% YoY Revenue
Best 1-Year Return
Sellas Life Sciences Group Inc
+697.4% Return